ClinicalTrials.Veeva

Menu

Impact of Parathyroidectomy on Cardiovascular Calcification in Dialysis-dependent Patients

S

Saint Petersburg State University, Russia

Status

Completed

Conditions

Dialysis
Vascular Calcification
Secondary Hyperparathyroidism
Chronic Kidney Disease Mineral and Bone Disorder

Study type

Observational

Funder types

Other

Identifiers

NCT03937349
Calcification

Details and patient eligibility

About

This is a prospective cohort study aimed to evaluate change of cardiovascular calcification after parathyroidectomy in patients with end-stage renal disease on dialysis compared with control group on conservative treatment.

Enrollment

63 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Age > 18 years
  2. ESRD patients receiving long-term hemodialysis or peritoneal dialysis treatment
  3. Severe secondary hyperparathyroidism defined as iPTH level > 800 pg/ml, followed with hypercalcemia and/or hyperphosphatemia; with presence of one or more nodular or diffuse parathyroid hyperplasia confirmed with CT

Exclusion criteria

  1. Primary hyperparathyroidosis as a cause of ESRD

Trial design

63 participants in 3 patient groups

sPTx group
Description:
Patients underwent subtotal parathyroidectomy due to severe secondary hyperparathyroidism
TPTx+AT group
Description:
Patients underwent total parathyroidectomy with immediate autotransplantation of parathyroid tissue due to severe secondary hyperparathyroidism
Control group
Description:
Patients with severe SHPT on conservative treatment (calcimimetics, active vitamin D analogues, phosphate-binders) who are likely to undergo surgery in a period of 12 months

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems